Dupixent® (dupilumab) is now approved in India for the treatment of adults with moderate-to-severe atopic dermatitis
Dupixent® (dupilumab) is now approved in India for the treatment of adults with moderat…
Dupixent® (dupilumab) is now approved in India for the treatment of adults with moderat…
40,000 Cybersecurity jobs in India currently, but skill gap stands at 30% - TeamLease D…
Research Analysts AMS Consulting (P) Limited Location: Lucknow, Uttar Pradesh …